Liquid Biopsy versus CT: Comparison of Tumor Burden Quantification in 1065 Patients with Metastases

0 avis

Liquid Biopsy versus CT: Comparison of Tumor Burden Quantification in 1065 Patients with Metastases

Archive ouverte

Edité par CCSD ; Radiological Society of North America -

International audience. Tumor fraction at liquid biopsy was weakly correlated with the total tumor volume at contrast-enhanced CT and did not accurately reflect the tumor burden at contrast-enhanced CT.

Langue: en

Consulter en ligne

Consulter le document

Suggestions

Du même auteur

Liquid Biopsies for Circulating Tumor DNA Detection May Reveal Occult Hematologic Malignancies in Patients With Solid Tumors

Archive ouverte | Aldea, Mihaela | CCSD

International audience. PURPOSE High-risk clonal hematopoiesis (CH) is frequently incidentally found in patients with solid tumors undergoing plasma cell–free DNA sequencing. Here, we aimed to determine if the incid...

Clinical utility of circulating tumor DNA sequencing with a large panel: a National Center for Precision Medicine (PRISM) study

Archive ouverte | Bayle, Arnauld | CCSD

International audience. Background: Circulating tumor DNA (ctDNA) sequencing is a promising approach for tailoring therapy in patients with cancer. We report hereby the results from a prospective study where we inve...

Genomic landscape of liquid biopsy mutations in TP53 and DNA damage genes in cancer patients

Archive ouverte | Vasseur, Damien | CCSD

International audience. Abstract Next-generation sequencing (NGS) assays based on plasma cell-free DNA (cfDNA) are increasingly used for clinical trials inclusion. Their optimized limit of detection applied to a lar...

Chargement des enrichissements...